Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen

被引：0
作者：
Ho, Matthew D. [1 ]
Yeo, Kiang-Teck J. [2 ]
Eggener, Scott E. [1 ]
机构：
[1] Univ Chicago, Dept Surg, Sect Urol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pathol, Sect Clin Chem, Chicago, IL USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2024年 / 161卷 / 01期
关键词：
free; prostate; specific; antigen; cancer; PSA; overtreatment; overdiagnosis; risk;
D O I：
10.1093/ajcp/aqad109
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [21] Prostate-specific Antigen Testing and Prostate Cancer Screening
    Djavan, Bob
    Eckersberger, Elisabeth
    Finkelstein, Julia
    Sadri, Helen
    Taneja, Samir S.
    Lepor, Herbert
    PRIMARY CARE, 2010, 37 (03): : 441 - +
  • [22] Prostate-Specific Antigen Doubling Time as a Predictor of Gleason Grade in Prostate Cancer
    Nowroozi, Mohammad Reza
    Zeighami, Shahryar
    Ayati, Mohsen
    Jamshidian, Hassan
    Ranjbaran, Ali Reza
    Moradi, Asaad
    Afsar, Firuzeh
    UROLOGY JOURNAL, 2009, 6 (01) : 27 - 30
  • [23] Prostate-Specific Antigen, Prostate Cancer, and Disorders of Hemostasis
    Lippi, Giuseppe
    Plebani, Mario
    Franchini, Massimo
    Guidi, Gian Cesare
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (07) : 654 - 664
  • [24] Effect of transrectal ultrasonography of the prostate on serum prostate-specific antigen levels and free/total prostate-specific antigen ratio
    Serel, TA
    Çetin, M
    Delibas, N
    Çelik, E
    Tahoglu, M
    UROLOGIA INTERNATIONALIS, 2000, 64 (01) : 24 - 26
  • [25] Lifestyle factors and prostate-specific antigen
    Wignall, Daniel
    Gkentzis, Agapios
    JOURNAL OF CLINICAL UROLOGY, 2023, 16 (05) : 506 - 510
  • [26] Is the era of prostate-specific antigen over?
    Djavan, Bob
    Rocco, Bernardo
    Stangelberger, Anton
    De Cobelli, Ottavio
    Marberger, Michael
    BJU INTERNATIONAL, 2007, 100 : 8 - 10
  • [27] Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer
    Payne, Heather
    Cornford, Philip
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (06) : 593 - 601
  • [28] The performance characteristics of prostate-specific antigen and prostate-specific antigen density in tOChinese men
    Teoh, Jeremy Y. C.
    Yuen, Steffi K. K.
    Tsu, James H. L.
    Wong, Charles K. W.
    Ho, Brian S. H.
    Ng, Ada T. L.
    Ma, Wai-Kit
    Ho, Kwan-Lun
    Yiu, Ming-Kwong
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (01) : 113 - 116
  • [29] Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level
    Törnblom, M
    Norming, U
    Becker, C
    Lilja, H
    Gustafsson, O
    BJU INTERNATIONAL, 2001, 87 (07) : 638 - 642
  • [30] Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis
    Gorday, William
    Sadrzadeh, Hossein
    de Koning, Lawrence
    Naugler, Christopher T.
    CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1230 - 1234
12345